Abstract
Gold nanoparticles may be used in different domains, one of most important being the biomedical field. They have suitable properties for controlled drug delivery, cancer treatment, biomedical imaging, diagnosis and many others, due to their excellent compatibility with the human organism, low toxicity and tunable stability, small dimensions, and possibility to interact with a variety of substances. They also have optical properties, being able to absorb infrared light. Moreover, due to their large surface and the ability of being coated with a variety of therapeutic agents, gold nanoparticles have been showed a great potential to be used as drug delivery systems. Gold nanoparticles are intensively studied in biomedicine, and recent studies revealed the fact that they can cross the blood-brain barrier, may interact with the DNA and produce genotoxic effects. Because of their ability of producing heat, they can target and kill the tumors, being used very often in photodynamic therapy. Gold nanoparticles can be synthesized in many ways, but the most common are the biological and chemical methods, however the chemical method offers the advantage of better controlling the size and shape of the nanoparticles. In this review, we present the principal applications of gold nanoparticles in the biomedical field, like cancer treatment, amyloid-like fibrillogenesis inhibitors, transplacental treatment, the development of specific scaffolds and drug delivery systems.
Keywords: Gold nanoparticles, Biomedical applications, Nanomedicine, Bioimaging, Targeting, Delivery, Biocompatibility.
Current Topics in Medicinal Chemistry
Title:Biomedical Applications of Gold Nanoparticles
Volume: 15 Issue: 16
Author(s): Daniela Cabuzu, Andreea Cirja, Rebecca Puiu and Alexandru Mihai Grumezescu
Affiliation:
Keywords: Gold nanoparticles, Biomedical applications, Nanomedicine, Bioimaging, Targeting, Delivery, Biocompatibility.
Abstract: Gold nanoparticles may be used in different domains, one of most important being the biomedical field. They have suitable properties for controlled drug delivery, cancer treatment, biomedical imaging, diagnosis and many others, due to their excellent compatibility with the human organism, low toxicity and tunable stability, small dimensions, and possibility to interact with a variety of substances. They also have optical properties, being able to absorb infrared light. Moreover, due to their large surface and the ability of being coated with a variety of therapeutic agents, gold nanoparticles have been showed a great potential to be used as drug delivery systems. Gold nanoparticles are intensively studied in biomedicine, and recent studies revealed the fact that they can cross the blood-brain barrier, may interact with the DNA and produce genotoxic effects. Because of their ability of producing heat, they can target and kill the tumors, being used very often in photodynamic therapy. Gold nanoparticles can be synthesized in many ways, but the most common are the biological and chemical methods, however the chemical method offers the advantage of better controlling the size and shape of the nanoparticles. In this review, we present the principal applications of gold nanoparticles in the biomedical field, like cancer treatment, amyloid-like fibrillogenesis inhibitors, transplacental treatment, the development of specific scaffolds and drug delivery systems.
Export Options
About this article
Cite this article as:
Cabuzu Daniela, Cirja Andreea, Puiu Rebecca and Grumezescu Mihai Alexandru, Biomedical Applications of Gold Nanoparticles, Current Topics in Medicinal Chemistry 2015; 15 (16) . https://dx.doi.org/10.2174/1568026615666150414144750
DOI https://dx.doi.org/10.2174/1568026615666150414144750 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
Call for Papers in Thematic Issues
AlphaFold in Medicinal Chemistry: Opportunities and Challenges
AlphaFold, a groundbreaking AI tool for protein structure prediction, is revolutionizing drug discovery. Its near-atomic accuracy unlocks new avenues for designing targeted drugs and performing efficient virtual screening. However, AlphaFold's static predictions lack the dynamic nature of proteins, crucial for understanding drug action. This is especially true for multi-domain proteins, ...read more
Artificial intelligence for Natural Products Discovery and Development
Our approach involves using computational methods to predict the potential therapeutic benefits of natural products by considering factors such as drug structure, targets, and interactions. We also employ multitarget analysis to understand the role of drug targets in disease pathways. We advocate for the use of artificial intelligence in predicting ...read more
Chemistry Based on Natural Products for Therapeutic Purposes
The development of new pharmaceuticals for a wide range of medical conditions has long relied on the identification of promising natural products (NPs). There are over sixty percent of cancer, infectious illness, and CNS disease medications that include an NP pharmacophore, according to the Food and Drug Administration. Since NP ...read more
Current Trends in Drug Discovery Based on Artificial Intelligence and Computer-Aided Drug Design
Drug development discovery has faced several challenges over the years. In fact, the evolution of classical approaches to modern methods using computational methods, or Computer-Aided Drug Design (CADD), has shown promising and essential results in any drug discovery campaign. Among these methods, molecular docking is one of the most notable ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Receptor Proteins for Nongenomic Actions of Thyroid Hormone
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Similar and Shared Nongenomic Mechanisms of Action of Estrogen and Thyroid Hormone
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Role of Second-Line Systemic Treatment Post-Docetaxel in Metastatic Castrate Resistant Prostate Cancer- Current Strategies and Future Directions
Anti-Cancer Agents in Medicinal Chemistry Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects
Current Alzheimer Research Nanoparticles-Based Treatment for Bone Metastasis
Current Drug Targets Application of Model-Based Approaches to Evaluate Hepatic Transporter-Mediated Drug Clearance: In vitro, In vivo, and In vitro-In vivo Extrapolation
Current Drug Metabolism Arene ruthenium(II) Complexes: The Promising Chemotherapeutic Agent in Inhibiting the Proliferation, Migration and Invasion
Mini-Reviews in Medicinal Chemistry Neuroprotective Effects of Nonsteroidal Anti-inflammatory Drugs on Neurodegenerative Diseases
Current Pharmaceutical Design Reversal of ABC Drug Transporter-Mediated Multidrug Resistance in Cancer Cells: Evaluation of Current Strategies
Current Molecular Pharmacology Antigenic Peptide Vaccination: Provoking Immune Response and Clinical Benefit for Cancer
Current Immunology Reviews (Discontinued) An Overview of Current Applications of Nanotechnology in Biomedical Research: A Patent Survey
Recent Patents on Nanomedicine Anti-EGFR Binding Nanobody Delivery System to Improve the Diagnosis and Treatment of Solid Tumours
Recent Patents on Anti-Cancer Drug Discovery Overexpression of p62 Induces Autophagy and Promotes Proliferation, Migration and Invasion of Nasopharyngeal Carcinoma Cells through Promoting ERK Signaling Pathway
Current Cancer Drug Targets Structure, Genome, Infection Cycle and Clinical Manifestations Associated with Human Papillomavirus
Current Pharmaceutical Biotechnology Poly (ADP-Ribosyl) Polymerase 1 Inhibitors: A Patent Review
Recent Patents on Anti-Cancer Drug Discovery Cytokines in Systemic Lupus Erythematosus
Current Molecular Medicine EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway
Current Cancer Drug Targets Bioproducts from Seaweeds: A Review with Special Focus on the Iberian Peninsula
Current Organic Chemistry New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention
Current Drug Targets Elucidation of PLK1 Linked Biomarkers in Oesophageal Cancer Cell Lines: A Step Towards Novel Signaling Pathways by p53 and PLK1-Linked Functions Crosstalk
Protein & Peptide Letters